In the news release, GenturaDx Announces Formation of Scientific Advisory Board, issued 22-Nov-2011 by GenturaDx over PR Newswire, we are advised by the company that the quote in the

Replacing conventional laboratory tests with a new DNA sequence-based technology to identify pathogens causing bloodstream infections dramatically lowered mortality and health-care costs.

MURRIETA, Calif., Oct.

With the increasing availability of sophisticated technologies to rapidly diagnose and treat infectious diseases, the duties and the role of clinical laboratory microbiologists, who traditionally perform these tests, could see significant changes in the next few years.

ZUG, Switzerland and ZURICH, Aug.